A healthy volunteer participates in a nutritional research study. After participants ingest a very fatty meal, serum samples are taken at 1 hour and 3 hours. The diameter of the chylomicrons is measured, showing an average chylomicron diameter of 500 nm at 1 hour, which decreases to an average diameter of 150 nm at 3 hours. At which of the following locations is the enzyme responsible for this change in chylomicron diameter most likely present? Select one: A. Myocytes B. Hepatocytes C. Enterocytes D. Endothelial cells E. Adipocytes A 40-year-old man with a 10-year history of type 1 diabetes mellitus comes to the physician for a routine examination. He was diagnosed with pancreatitis 25 years ago after a 2-year history of recurrent abdominal pain. Physical examination shows a thin habitus and abdominal tenderness. After a 12-hour fast, his serum triglyceride concentration is 4000 mg/dL (normal = 60-140 mg/dL). Intravenous heparin is administered in order to examine the activity of __________ enzyme. Select one: A. Phospholipase C B. Phospholipase A2 C. Lipoprotein lipase D. Hepatic lipase E. Hormone-sensitive lipase A young boy is brought to his pediatrician with complains of ataxic gait and visual impairments. On physical examination, the physician finds reduced reflexes in all extremities. Blood biochemistry shows with very low levels triacylglycerols. Examination of intestinal epithelial cells shows lipid-laden cells. A possible defect leading to these findings is which of the following? Select one: A. Apolipoprotein C-II overexpression B. LPL deficiency C. LCAT overexpression D. MTP deficiency E. CETP deficiency What tissues (denoted by a red question mark) are the primary site for the degradation of TAGs carried by CMs? Select one: A. Liver B. Brain C. Muscle D. Adipose tissue E. Kidneys What enzyme (denoted by a green question mark) degrades the TAGs? Select one: A. Phospholipase A2 B. Pancreatic lipase C. Adipose lipase D. Hepatic lipase E. Capillary lipase What molecule is the initial acceptor of FAs during TAG synthesis, as shown? Select one: A. GAHP B. Glycerol-3P C. Glycerol D. 2-MAG E. DHAP A patient told her doctor that a friend told her that if she ate only carbohydrates and proteins and no fats, she would no longer store fats in adipose tissue. The doctor told the patient her friend was misinformed and then should further respond to this statement via which one of the following? Select one: A. Dietary glucose is converted by the liver into fatty acids and glycerol. B. Dietary glucose is converted into fatty acids but not glycerol by the liver. C. Dietary glucose is converted into glycerol but not fatty acids by the liver. D. Low-density lipoprotein transports the dietary converted products to the muscle tissue for oxidation. E. Low-density lipoprotein transports the dietary converted products from the liver to the adipose tissue. Following a high-carbohydrates meal, ATP and NADHH+ levels in cell increase, which inhibits a mitochondrial enzyme. This results in increased levels of a molecule that will be directed fatty acid synthesis. Which enzyme is inhibited? Select one: A. Alfa-ketoglutarate dehydrogenase B. Citrate synthase C. Isocitrate dehydrogenase D. Pyruvate dehydrogenase E. Succinyl CoA synthase A medical student is spending his research year studying the physiology of cholesterol transport within the body. Specifically, he wants to examine how high density lipoprotein (HDL) particles are able to give other lipoproteins the ability to hydrolyse triglycerides into free fatty acids. He labels all the proteins on HDL particles with a tracer dye and finds that some of them are transferred onto very low density lipoprotein (VLDL) particles after the 2 are incubated together. Furthermore, he finds that only VLDL particles with transferred proteins are able to catalyze triglyceride hydrolysis. Which of the following components were most likely transferred from HDL to VLDL particles to enable this reaction? Select one: A. Apo-A1 B. Apo-E C. Apo-CII D. Lipoprotein lipase E. Apo-B100 Which of the following statements best distinguishes VLDL from chylomicrons? Select one: A. Only VLDL are produced during periods of starvation B. Only chylomicrons are produced by the liver C. VLDL have a higher percentage of triglyceride than chylomicrons D. Only chylomicrons are involved in the delivery of triglyceride to the adipocyte E. Only chylomicrons contain phospholipids and cholesteryl esters Pattern of Single Gene Inheritance 1 Basic Concepts Monogenic (single-gene)traits are known as mendelian traits More than 16,000 traits or disorders in humans exhibit single gene, monogenic, unifactorial or mendelian inheritance. The 44 autosomes comprise 22 homologous pairs of chromosomes. Each gene occupies a specific location or locus. The paired autosomal genes have one member of maternal and the other of paternal origin referred to as alleles. Basic Concepts Of these 23,000 genes and traits, nearly 21,000 are located on autosomes, more than 1,200 are located on the X chromosome, and 59 are located on the Y chromosome. A trait or disorder that is determined by a gene on an autosome is said to show autosomal inheritance, whereas a trait or disorder determined by a gene on one of the sex chromosomes is said to show sex-linked inheritance. Basic Concepts The GENOTYPE is the set of alleles that an individual organism possesses. A diploid organism with a genotype consisting of two identical alleles is Homozygous for that locus. An organism that has a genotype consisting of two different alleles is Heterozygous for the locus. The term Compound Heterozygote is used to describe a genotype in which two different/distinct mutant alleles of the same gene are present the locus. Basic Concepts PHENOTYPE or trait is the manifestation or appearance of a characteristic. It can refer to any type of characteristic: physical, physiological, biochemical, or behavioral. The two (2) Principles of Mendelian Inheritance (Meiosis): 1. The principle of Segregation states that each individual diploid organism possesses two alleles for any specific trait. These two alleles segregate when gametes are formed, and one allele goes into each gamete. 2. The principle of Independent Assortment states that genes at different loci are transmitted independently. principle of Segregation During the first meiotic division, homologous chromosomes pair. Each chromosome has an allele for a trait. The physical separation of the two chromosomes segregates the alleles from each other in anaphase Each allele will reside in different gametes. principle of Independent Assortment Principles of Mendelian Inheritance Mendel’s law of segregation states the following: The two copies of a gene segregate (or separate) from each other during transmission from parent to offspring. Mendel’s law of independent assortment states the following: Two different genes will randomly assort their alleles during the formation of haploid cells. (The allele for one gene will be found within a resulting gamete independently of whether the allele for a different gene is found in the same gamete) Basic Concepts PEDIGREE illustrates the relationships among family members, and it shows which family members are affected or unaffected by a genetic disease. The first person in whom the disease is diagnosed in the pedigree is termed the Proband or the Index Case or Propositus (proposita for a female). A horizontal line connecting a circle and a square represents a mating. Basic Concepts The extended family depicted in such pedigrees is a kindred Brothers and sisters are called sibs, and a family of sibs forms a sibship. Couples who have one or more ancestors in common are consanguineous. If only one member in a family is affected, he or she is an isolated case. If the disorder is determined to be due to new mutation in the propositus, a sporadic case. Basic Concepts The concept of dominance states that, when two different alleles are present in a genotype, only the trait encoded by one of them, the “dominant” allele, is observed in the phenotype. FITNESS is defined as the number of offspring affected with the condition who survive to reproductive age. Fitness is not a measure of physical or mental disability. In some disorders, an affected individual can have normal mental capacities and health but have a fitness of 0 because the condition interferes with normal reproduction. Basic Concepts The patterns shown by single-gene disorders in pedigrees depend mainly on two factors: 1. whether the phenotype is DOMINANT (expressed when one chromosome of a pair carries the mutant allele and the other chromosome has a wild-type at that locus) or RECESSIVE (expressed when both chromosomes of a pair carry mutant alleles at a locus). 2. the CHROMOSOMAL LOCATION of the gene locus, which may be on an autosome (chromosomes 1 to 22) or on a sex chromosome (chromosomes X and Y). Basic Concepts In dominant inheritance a phenotype expressed in both homozygotes and heterozygotes for a mutant allele is inherited as a dominant. In a PURE DOMINANT DISEASE, homozygotes and heterozygotes for the mutant allele are both affected equally. (rare) Dominant disorders are more severe in homozygotes than in heterozygotes, in which case the disease is called INCOMPLETE DOMINANT (or SEMIDOMINANT). Basic Concepts PENETRANCE is the probability that a gene will have any phenotypic expression. When some persons who have the appropriate genotype completely fail to express it, the gene is said to show Reduced Penetrance. EXPRESSIVITY is the severity of expression of phenotype among individuals with the same disease-causing genotype. When the severity of disease differs in people who have the same genotype, the phenotype is said to have Variable Expressivity. ANTICIPATION occurs in some autosomal dominant and X-linked recessive disorders where the onset of the disease occurs at an earlier age in the offspring than in the parents, or the disease occurs with increasing severity in subsequent generations. Basic Concepts The relationship between single-gene mutations and disease phenotypes vary because of GENETIC HETEROGENEITY. This may result from: 1. Different mutations at the same locus termed Allelic Heterogeneity. (e.g. Cystic Fibrosis CFTR gene) 2. Mutations at different loci termed Locus Heterogeneity (e.g. in Retinitis pigmentosa 43 loci are responsible for 5 X-linked forms, 14 for autosomal dominant forms, and 24 for autosomal recessive forms Basic Concepts Different mutations in the same gene can sometimes give rise to very different phenotypes. This is called PHENOTYPIC HETEROGENEITY. For example, a mutation in the RET gene which encodes a receptor tyrosine kinase can cause Hirschsprung disease, Multiple Endocrine Neoplasia type 2A and 2B or both in some individuals . Basic Concepts PLEIOTROPY: is the term used when multiple phenotypic effects observe from a single allele or pair of alleles. The term is used particularly when the effects are seemingly unrelated. Basic Concepts A PUNNETT SQUARE is a graphical representation of the possible genotypes of an offspring arising from a specific breeding event. It requires knowledge of the genetic composition of the parents. The various possible combinations of their gametes are encapsulated in a tabular format. Each box in the table represents a fertilization event. The Punnett Square is a visual representation of Mendelian Inheritance. Basic Concept of Probability PROBABILITY indicate the likelihood of the occurrence of a specific event. It is the number of times that an event occurs, divided by the number of all possible outcomes. Probability can be expressed either as a fraction or a decimal number. RISK RECURRENCE PROBABILITY, that future children of parents affected by a genetic disease will also be affected. Two rules of probability are useful for predicting the ratios of offspring produced in genetic crosses. The multiplication rule and the addition rule Basic Concept of Probability The MULTIPLICATION RULE states that the probability of two or more independent events occurring together is calculated by multiplying their independent probabilities Suppose a couple wants to know the probability that all three of their planned children will be girls. Because the probability of producing a girl is 1/2, and because reproductive events are independent of one another, the probability of producing three girls is 1/2 × 1/2 × 1/2 = 1/8. However, if the couple already has two girls and then wants to know the probability of producing a third girl, it is simply 1/2. The past events have no effect on the outcome of the third event. Basic Concept of Probability The ADDITION RULE states that the probability of any one of two or more mutually exclusive events occurring and is calculated by adding the probabilities of these events. Mutually exclusive means that one event excludes the possibility of the occurrence of the other event. Imagine that a couple plans to have three children, and they have a strong aversion to having three children all the same sex. They can be reassured knowing that the probability of producing three girls or three boys is only 1/8 + 1/8, or 1/4. Basic Concept of Probability The probability that they will have some combination of boys and girls is 3/4 because the sum of the probabilities of all possible outcomes must add up to 1. Basic probability enables us to understand and estimate genetic risks and to understand genetic variation among populations. The multiplication rule is used to estimate the probability that TWO EVENTS INDEPENDENT WILL OCCUR TOGETHER. The addition rule is used to estimate the probability that ONE EVENT OR ANOTHER WILL OCCUR. Autosomal Dominant Inheritance Pattern of Inheritance An autosomal dominant trait is one that manifests phenotypically in the heterozygous state. Each gamete from an individual with a dominant trait or disorder will contain either the normal allele or the mutant allele. With the dominant mutant allele as ‘D’ and the normal allele as ‘d’. The possible combinations of the gametes is seen in the image. Pattern of Inheritance Affected offspring are produced by the union of an unaffected parent with an affected heterozygote. The risk and severity of dominantly inherited disease in the offspring depend on: 1. whether one or both parents are affected 2. whether the trait is strictly dominant or incompletely dominant. Features of Autosomal Dominant Inheritance 1. Traits appear in both sexes with equal frequency, and both sexes can transmit these traits to their offspring. 2. Traits do not skip generations in the pedigree analysis. (Exceptions to this rule arise when people acquire the trait as a result of a new mutation or when the trait has reduced penetrance. Features of Autosomal Dominant Inheritance 3. When one parent is heterozygous affected, and the other parent is unaffected 1/2 of the offspring will be affected. 4. When both parents have the trait and are heterozygous, approximately 3/4 of the children will be affected. 5. Unaffected people do not transmit the trait to their descendants, provided that the trait is fully penetrant. Achondroplasia Achondroplasia is the most common cause of human dwarfism. It is an autosomal dominant disorder caused by specific mutations in FGFR3. Two distinct point substitutions account for more than 99% of cases of achondroplasia. Achondroplasia The G1138A mutation accounts for 98% of the cases, resulting in a G-to-A DNA nucleotide point change. The G1138C mutation (1-2%) results from G-to-C DNA point change. The FGFR3 mutations associated with achondroplasia are gain-of-function mutations. Achondroplasia has an incidence of 1 in 15,000 to 1 in 40,000 live births and affects all ethnic groups. Familial hypercholesterolemia (FH) This autosomal dominant condition is due to a single mutant gene on the short arm of chromosome 19. This leads to a loss of function in the LDL receptor (LDLR). The LDLR, a transmembrane glycoprotein is mainly expressed in the liver and adrenal cortex, plays a key role in cholesterol homeostasis. It binds apolipoprotein B-100 and apolipoprotein E, intermediate-density lipoproteins, and chylomicron remnants. Familial hypercholesterolemia (FH) Homozygous or heterozygous mutations of LDLR decrease the efficiency of intermediate-density lipoprotein and LDL endocytosis. Accumulation of plasma LDL follows, because of increasing production of LDL from intermediate-density lipoproteins and decreasing hepatic clearance of LDL. Ultimately atherosclerosis occurs. FH occurs among all races and has a prevalence of 1 in 500 in most white populations. Familial hypercholesterolemia (FH) Clinical manifestations include arcus corneae and tendon xanthomas and CAD (coronary artery disease). Incomplete Dominance is seen in FH: Homozygous FH presents in the first decade with tendon xanthomas and arcus corneae. If left untreated, death occurs by age 30. Heterozygous FH are less severe with arcus corneae and tendon xanthomas begin to appear by the end of the second decade. Neurofibromatosis 1 NEUROFIBROMATOSIS 1(NF1) is the most common an autosomal dominant disorder (1:3500) It results from mutations in the neurofibromin gene (NF1), located on chromosome 17q. It encodes for neurofibromin, which regulates many cellular processes including activation of Ras GTPase that controls cell proliferation and tumor suppression. Neurofibromatosis 1 Many different mutations have been identified in neurofibromin-1, including deletions, insertions, duplications, and point substitutions (allelic heterogeneity ). Most lead to severe truncation of the protein or complete absence of gene expression. NF1 is characterized by variable expression. No clear genotype-phenotype correlations have been recognized. NF1 is a multisystem disorder with neurological, musculoskeletal, ophthalmological, and skin abnormalities and a predisposition to neoplasia Neurofibromatosis 1 Major Phenotypic manifestations include: Age at onset: Prenatal to late childhood Café au lait spots Axillary and inguinal freckling Cutaneous neurofibromas Lisch nodules (iris hamartomas) Plexiform neurofibromas Optic glioma Specific osseous lesions Neurofibromatosis 1 Principles • Variable expressivity • Extreme pleiotropy • Tumor-suppressor gene • Loss-of-function mutations • Allelic heterogeneity • De novo mutations Marfan Syndrome Marfan syndrome is a pan-ethnic, autosomal dominant, connective tissue disorder that results from mutations in the fibrillin 1 (FBN 1)gene located on 15q. It has an incidence of approximately 1 in 5000. FBN1 encodes fibrillin 1, an extracellular matrix glycoprotein with wide distribution. Fibrillin 1 polymerizes to form microfibrils in both elastic and nonelastic tissues, such as the aortic adventitia, ciliary zonules, and skin. Marfan Syndrome Mutations affect fibrillin 1 synthesis, processing, secretion, polymerization, or stability. The production of mutant fibrillin 1 is a dominant negative pathogenesis causing: Inhibition of the formation of normal microfibrils by normal fibrillin 1 Stimulation of inappropriate proteolysis of extracellular microfibrils. Haploinsufficiency also occurs Marfan Syndrome Marfan syndrome is a multisystem disorder with skeletal, ocular, cardiovascular, pulmonary, skin, and dural abnormalities. The skeletal abnormalities include disproportionate tall stature, arachnodactyly, pectus deformities, scoliosis, joint laxity, and narrow palate. Ocular abnormalities associated with Marfan syndrome are ectopia lentis, flat corneas, and increased globe length causing axial myopia. The cardiovascular abnormalities include mitral valve prolapse, aortic regurgitation, and dilatation and dissection of the ascending aorta. Myotonic Dystrophy 1 Autosomal dominant inheritance with increasing severity in succeeding generations—anticipation A dynamic mutation resulting from CTG repeats in the 3′ UTR region of the DMPK gene on 19q13.3. Disease mutation is 50 to > –2000 repeats The DMPK gene provides instructions for making a protein called myotonic dystrophy protein kinase. Clinical manifestation include muscle weakness and wasting Myotonia, prolonged muscle contractions and not able to relax certain muscles after use. For example, a person may have difficulty releasing their grip on a doorknob or handle Cataracts, Cardiac conduction defects Myotonic Dystrophy 2 Autosomal dominant disorder caused a tetranucleotide repeat A dynamic mutation expansion occurs in intron 1 of CNBP (also known as ZNF9) a gene on 3q21.3. People with type 2 myotonic dystrophy have from 75 to more than 11,000 CCTG repeats. PEDIGREE FOR AUTOSOMAL DOMINANT 45 Pedigree for Autosomal dominant Autosomal Recessive Disorders Autosomal Recessive Inheritance Autosomal recessive disease occurs only in homozygotes or compound heterozygotes When a disorder shows recessive inheritance, the mutant allele responsible generally reduces or eliminates the function of the gene product (a loss-offunction mutation). The remaining normal gene copy in a heterozygote can compensate for the mutant allele and prevent the full phenotypic expression of the disease. Pattern of Inheritance Three types of matings can lead to homozygous offspring affected with an autosomal recessive disease. The most common mating is between two unaffected heterozygotes, referred to as Carriers. If we represent the normal dominant allele as R and the recessive mutant allele as r, then each parental gamete carries either the mutant or the normal allele. The possible combinations of the gametes is seen in the image. Pattern of Inheritance 75% of the offspring of this mating will not have the disease. Of this 75%; 2/3 will be Carriers and 1/3 homozygous normal 25% of the offspring will be affected and homozygous mutant Features of Autosomal Recessive Inheritance 1. Autosomal recessive traits appear with equal frequency in males and females.. 2. Affected children inherits two mutant alleles and are commonly born to unaffected parents who are carriers of the gene for the trait. 3. Whenever both parents are heterozygous, approximately one-fourth of the offspring are expected to express the trait. The recurrence risk is 1 in 4. Features of Autosomal Recessive Inheritance 4. Recessive traits appear more frequently among the offspring of consanguine matings. 5. In the rare event that both parents are affected by an autosomal recessive trait, all the offspring will be affected Cystic Fibrosis CYSTIC FIBROSIS is an autosomal recessive disorder incidence is approximately 1 in 2000. The gene that encodes the cystic fibrosis transmembrane conductance regulator (CFTR) protein on 7q. The CFTR protein has ~ 1480 amino acids. Most common is the Phe508del (3 base pair deletion which results in the loss of a phenylalanine residue More than 1500 mutations in the CFTR gene have been identified. These include missense, frameshift, splice site, nonsense, and deletion mutations (allelic heterogeneity) The primary role of the CFTR protein is to act as a chloride channel. The net effect of all these mutations is to reduce the normal functional activity of the CFTR protein, Mutant alleles may be handed down from carrier to carrier for numerous generations without ever appearing in the homozygous state causing overt disease. The presence of such hidden recessive genes is not revealed until the carrier mates with someone who also carries a mutant allele at the same locus and the two deleterious alleles are both inherited by a child. Chronic lung disease caused by recurrent infection eventually leads to fibrotic changes in the lungs with secondary cardiac failure(Cor Pulmonale). Pancreatic dysfunction from blockage of the pancreatic ducts by inspissated secretions causes malabsorption and steatorrhea. Pleiotropy is observed in CF Sickle Cell Disease Sickle cell disease is an autosomal recessive disorder of hemoglobin in which the β subunit genes have a missense mutation that substitutes valine for glutamic acid at amino acid 6. This mutation occurs on 11p. Hemoglobin C (Hb C) is a structural variant of normal hemoglobin A (Hb A) caused by an amino acid substitution of lysine for glutamic acid at position six of the beta hemoglobin chain. Persons with hemoglobin C trait (Hb AC) are phenotypically normal. Those with hemoglobin C disease (Hb CC) have a mild hemolytic anemia (jaundice), splenomegaly, and borderline anemia due to crystal formation of RBCs When a sickle cell carrier and a Hb C carrier mate their progeny are illustrated in the following pedigree. The offspring SC is diseased and will have phenotypical manifestation. That offspring is a Compound Heterozygote. Sickle cell anemia (homozygosity for HbS) is noteworthy for its PLEIOTROPY Approximately 1 in 600 African Americans is born with this disease, which may be fatal in early childhood, although longer survival is becoming more common. The disease occurs most frequently in equatorial Africa and less commonly in the Mediterranean area and India Phenylketonuria PHENYLKETONURIA (PKU) is an inherited disorder with increased levels of phenylalanine in the blood due to a deficiency of phenylalanine hydroxylase. It is the most common inborn error of amino acid metabolism. PKU is caused by mutations in the PAH gene found 12q. Phenylketonuria The PKU shows allelic heterogeneity. Mutations have been described in all 13 exons of the PAH gene and its flanking region. The mutations types include missense mutations (62% of PAH alleles), small or large deletions (13%), splicing defects (11%), silent polymorphisms (6%), nonsense mutations (5%), and insertions (2%). PKU displays pleiotropy as well. Pattern of Single Gene inheritance 2 Sex Linked Inheritance Sex-linked inheritance refers to the pattern of inheritance shown by genes that are located on either of the sex chromosomes. Genes carried on the X chromosome are referred to as being X-linked inheritance. Those carried on the Y chromosome are referred to as exhibiting Y-linked or holandric inheritance. Sex Linked Inheritance A female has two X chromosomes: one of paternal and one of maternal origin termed homozygous. Males have only one X chromosome therefore only one copy of each X - linked gene termed hemizygous. In females one of these X chromosomes is inactivated in each somatic cell. This mechanism ensures that the quantity of most X - linked gene products generated in somatic cells of the female is equal to the amount in male cells. X - Inactivation X inactivation or Lyonization is a normal physiological process in which one of the two X chromosomes in the female embryoblast is inactivated in the somatic cells. One of the two X chromosomes is randomly chosen for inactivation (i.e. either the paternal or maternal). That inactive X chromosome remains inactive during subsequent mitosis of that cell. In the trophoblastic cells the paternal X is preferentially inactivated. In oogonia the inactive chromosome is reactivated. X -Inactivation As a result of X inactivation, all females have two distinct populations of cells: One population with a paternally active X chromosome Another population maternally active X chromosome. This makes females mosaics for X chromosome activity. X - Inactivation X chromosome inactivation begins at a site called the X inactivation center (XIC). XIST (X inactive specific transcript) gene is located within the XIC. The RNA produced by XIST gene is highly expressed from the inactive X chromosome (Xi) during the onset of XCI but not from the active X chromosome (Xa). Xist RNA is an interference RNA (RNAi). 1. 2. X - Inactivation Xist RNA or RNAi coats the X chromosome and forms an “Xist cloud” over the Xi. The Xist cloud acts as a scaffold for the recruitment of silencing factors e.g. Polycomb repressive complex 2 (PRC2) and DNA methylation. X -Inactivation Inactive X chromosomes (Xi) during interphase condense into a darkly staining mass associated with the nuclear membrane called a Barr body. The Barr body decondenses during S phase to allow the inactive X chromosome to be replicated. Skewed X inactivation In most females the number of cells with either Xi and Xa is roughly equal. Dosage equivalency for X-linked genes between XY males and XX females is achieved. However, skewing of X chromosome inactivation is observed in a percentage of women. This is deviation from equal (50%) inactivation of each parental allele. Skewed X inactivation Skewed X inactivation is defined as the observation of inactivation of the same allele in 75% or 80% of cells (and very skewed inactivation resulting in 90% or 95% of cells with the same allele inactive). Skewed X Inactivation Skewing of XCI can reflect or result in biological consequences for females. Depending on the pattern of random X inactivation of the two X chromosomes, two female heterozygotes for an X-linked disease can present distinct clinical manifestation. This results from the variation in the proportion of cells that have the mutant allele on the active X in a relevant tissue. X- Linked Inheritance Dominant Recessive X - linked Inheritance X-linked patterns of inheritance are distinguished based on the phenotype in heterozygous females. Some X-linked phenotypes are consistently expressed in carriers termed DOMINANT. Others that are not typically carrier expressed are RECESSIVE. X-linked Recessive Females inherit two copies of the X chromosome and can be: Homozygous for a mutant allele at a given locus Heterozygous at the locus (mutant and wild-type) Homozygous for the normal (wild type) allele at the locus. In this way, X-linked loci in females are like autosomal loci. However, X inactivation leaves only one copy of the allele in an individual somatic cell. Half of the cells in a heterozygous female will express the disease allele and half will express the normal allele. (VARIABLE EXPRESSION) X-linked Recessive As with autosomal recessive traits, the heterozygote will produce about 50% of the normal level of the gene product enough for a normal phenotype. In males, who are hemizygous for the X chromosome. An inherited recessive gene on the X chromosome will manifest the disorder. The Y chromosome does not carry a normal allele to compensate for the effects of the disease allele. X-linked Recessive An X-LINKED RECESSIVE trait (disorder) is one determined by a gene carried on the X chromosome and usually manifests only in males. A male with a mutant allele on his single X chromosome is said to be hemizygous for that allele. In addition, affected males pass this trait to their obligate carrier daughters, with a consequent risk to male grandchildren through these daughters. X-linked Recessive Features of X-Linked Recessive Inheritance The incidence of traits are higher in males than in females. Heterozygous females are usually unaffected. The gene responsible for the condition is transmitted from an affected man through all his daughters. Sons of his daughters has a 50% chance of inheriting it. features of X-Linked Recessive Inheritance The mutant allele is never transmitted directly from father to son. The mutant allele may be transmitted through a series of carrier females; affected males in a kindred are related through these females. A significant proportion of isolated cases are due to new mutation Duchenne Muscular Dystrophy Duchenne muscular dystrophy (DMD,) is X-linked recessive progressive myopathy caused by mutations within the DMD gene. DMD encodes for dystrophin, an intracellular protein that is expressed predominantly in smooth, skeletal, and cardiac muscle as well as in some brain neurons. In skeletal muscle, dystrophin is part of a large complex of sarcolemma-associated proteins that confers stability to the sarcolemma. Duchenne Muscular Dystrophy DMD mutations include large deletions (60% to 65%), large duplications (5% to 10%), and small deletions, insertions, or nucleotide changes (25% to 30%). Allelic heterogeneity Clinical manifestations include muscle degeneration and weakness. Begins at the hip girdle muscles and neck flexors, then progresses to involve the shoulder girdle and distal limb and trunk muscles. Male patients usually present between the ages of 3 and 5 years with gait abnormalities. By 5 years, most patients use a Gowers maneuver and have calf pseudohypertrophy Duchenne Muscular Dystrophy By 12 years of age, most patients are confined to a wheelchair and have or are developing contractures and scoliosis. Most die of impaired pulmonary function and pneumonia; the median age at death is 18 years. Nearly 95% of patients with DMD have some cardiac compromise (dilated cardiomyopathy, electrocardiographic abnormalities, or both). Duchenne Muscular Dystrophy The age at onset and the severity of DMD in females depend on the degree of skewing of X inactivation. If the X chromosome carrying the mutant DMD allele is active in most cells, females develop signs of DMD; if the X chromosome carrying the normal DMD allele is predominantly active, females have few or no symptoms of DMD. Glucose-6-Phosphate Dehydrogenase Deficiency G6PD deficiency is an X-linked recessive disorder caused by mutations in the G6PD gene. G6PD deficiency mutations in the G6PD gene decrease the catalytic activity or the stability of G6PD, or both. G6PD is the first enzyme in the hexose monophosphate shunt, a pathway critical for generating nicotinamide adenine dinucleotide phosphate (NADPH). NADPH is required for the regeneration of reduced glutathione. Glucose-6-Phosphate Dehydrogenase Deficiency Insufficient in NADPH availability leads to reduced regeneration of glutathione during times of oxidative stress. The result is the oxidation and aggregation of intracellular proteins (Heinz bodies) and the formation of rigid erythrocytes that readily hemolyze. Glucose-6-Phosphate Dehydrogenase Deficiency The severity of G6PD deficiency depends not only on sex, but also on the specific G6PD mutation. In general, the mutation common in the Mediterranean basin (G6PD B−variant or Mediterranean) tends to be more severe than those mutations common in Africa (G6PD A− variants). G6PD deficiency most commonly manifests as either neonatal jaundice or acute hemolytic anemia. Viral and bacterial infections are the most common triggers, but many drugs and toxins can also precipitate hemolysis. Glucose-6-Phosphate Dehydrogenase Deficiency The disorder called favism results from hemolysis secondary to the ingestion of fava beans by patients with more severe forms of G6PD deficiency, such as G6PD Mediterranean. Fava (broad) beans contain β-glycosides, a naturally occurring oxidants. Lesch - Nyhan Syndrome Lesch-Nyhan disease is caused by mutations in the HPRT gene on the X chromosome. Hypoxanthine-guanine phosphoribosyl transferase (HPRT) plays a key role in the recycling of the purine bases, hypoxanthine (inosine) and guanine, into the purine nucleotide pools The mutations are heterogeneous, with more than 600 different ones documented, including single base substitutions, deletions, insertions, or substitutions. Allelic heterogeneity Lesch - Nyhan Syndrome In the absence of HPRT, purine bases are not salvaged but degraded and excreted as uric acid. Uric acid production increase with subsequent hyperuricemia. Hyperuricemia increases the risk of uric acid crystal precipitation in the tissues to form tophi. In addition to failed purine recycling, the rate of purine synthesis is accelerated to compensate for purines lost in the salvage process. Lesch - Nyhan Syndrome LNS is associated with 3 major clinical elements: OVERPRODUCTION OF URIC ACID – characterized by nephrolithiasis with renal failure, gouty arthritis, and solid subcutaneous deposits known as tophi NEUROLOGIC DISABILITY – dominated by dystonia but may include choreoathetosis, ballismus, spasticity, or hyperreflexia. BEHAVIORAL PROBLEMS – include intellectual disability aggressive and impulsive behaviors (persistent self- injurious behavior). X – Linked Dominant In X-linked dominant disorders manifest in the heterozygous female and hemizygous males with the mutant allele on his single X chromosome. Both the daughters and sons of an affected female have a 1 in 2 (50%) chance of being affected. An affected male transmits the trait to all his daughters but to none of his sons. There is no male-to-male transmission. Features of X-Linked Dominant Inheritance Both male and female offspring of female carriers have a 50% risk of inheriting the phenotype. Both males and females (heterozygous) can be affected. Affected females are about twice as common as affected males but have milder expression of the phenotype. X – linked Dominant Fragile X Syndrome Fragile X syndrome is an X-linked disorder of intellectual disability that is caused by mutations in the FMR1 gene on Xq27.3 The FMR1 gene product is expressed in many cell types but most abundantly in neurons. The FMRP protein chaperone a subclass of mRNAs from the nucleus to the translational machinery. FMR1 dynamic mutations are expansions of a (CGG)n repeat sequence in the 5′ untranslated region (UTR) of the gene. Fragile X Syndrome In normal alleles of FMR1, the number of CGG repeats ranges from 6 to about 50. In disease-causing alleles or full mutations, the number of repeats is more than 200. Alleles with > 200 CGG repeats usually have hypermethylation of the CGG repeat sequence and the adjacent FMR1 promoter which leads to inactivation (silencing) and loss of FMRP expression. Fragile X Syndrome Mutable alleles (~ 59 to 200 CGG repeats) occurs from maternal transmission of a mutant FMR1 allele. Mutable alleles are often shortened with paternal transmission. Full mutations do not arise from normal alleles. The severity of the phenotype depends on repeat length mosaicism and repeat methylation (Anticipation) Fragile X Syndrome Fragile X syndrome causes moderate intellectual disability in affected males and mild intellectual deficits in affected females. Most affected individuals also have behavioral abnormalities, including hyperactivity, hand flapping or biting, temper tantrums, poor eye contact, and autistic features. Characteristic features include a long narrow face, large ears, a prominent jaw and forehead, unusually flexible fingers, flat feet and in males, enlarged testicles (macroorchidism) after puberty become more apparent with age. X-linked hypophosphatemia X-linked hypophosphatemia (XLH) is a dominant disorder and accounts for more than 80% of all familial hypophosphatemia. This loss of function mutation of the phosphate-regulating endopeptidases on the X chromosome (PHEX), leads to low levels of phosphate in the blood (hypophosphatemia). The gene product zinc-metallopeptidase is responsible for the catabolism and circulatory clearance of fibroblast growth factor-23 (FGF23). X-linked hypophosphatemia FGF23 acts on the kidney to cause increased phosphate excretion and decreased alpha-1 hydroxylase activity. The resulting over activity of this FGF23 reduces phosphate reabsorption by the kidneys, leading to hypophosphatemia and the related features. Symptoms become apparent within the first 18 months of life, when a child begins to bear weight on the legs. X-linked hypophosphatemia Clinical manifestations include Abnormal bone development (leading to bowing or twisting of the lower legs) and short stature or a slowing growth rate. Abnormal tooth development Bone pain, muscle pain and weakness Rett Syndrome Rett syndrome is an X-linked dominant disorder with a female prevalence of 1 in 10,000 to 1 in 15,000. It is caused by loss-of-function mutations of the MECP2 gene. MECP2 encodes a nuclear protein that binds methylated DNA and recruit histone deacetylases to regions of methylated DNA. Its dysfunction is believed to cause inappropriate activation of target genes because of failed gene repression (silencing) Rett Syndrome Classic Rett syndrome is a progressive neurodevelopmental disorder occurring almost exclusively in girls. After apparently normal development until 6 to 18 months; a short period of developmental slowing and stagnation with decelerating head growth Loss of speech and acquired motor skills follows. They develop stereotypic hand movements, breathing irregularities, ataxia, and seizures. Alport Syndrome Alport syndrome refers to a group of inherited, heterogeneous disorders involving the basement membranes of the kidney and affecting the cochlea and eye. These disorders are the result of mutations in type IV collagen genes which is the major constituent of the GBM (glomerular basement membrane). The alpha-5 (IV) and alpha-6 (IV) chains are encoded by genes COL4A5 and COL4A6, respectively, on the X chromosome Alport Syndrome Three (3) genetic forms of Alport syndrome exist (LOCUS HETEROGENEITY): XLAS - Results from mutations in the COL4A5 gene; accounts for 85% of cases of Alport syndrome Autosomal recessive Alport syndrome (ARAS) caused by mutations in the COL4A3 or COL4A4 gene; responsible for ~10-15% of cases Autosomal dominant Alport syndrome (ADAS) is rare; caused by mutations in the COL4A3 or COL4A4 Alport Syndrome Phenotypical expression is characterized by kidney disease, hearing loss, and eye abnormalities. Renal manifestations include hematuria, proteinuria and hypertension Sensorineural hearing loss Ocular manifestations include anterior lenticonus, dot and flecks retinopathy and posterior polymorphous corneal dystrophy Y-Linked Inheritance The Y chromosome approximately 60 Mb of DNA, contains relatively few genes. These gene Initiates differentiation of the embryo into a male, Several genes that encode testis specific spermatogenesis factors, A minor histocompatibility antigen (termed HY) Several housekeeping genes, which all have inactivation escaping homologues on the X chromosome. Y-Linked Inheritance Transmission of Y-linked traits is strictly from father to son. A mutation on the DFNY1 gene can cause hearing loss. This Y-linked deafness-1 (DFNY1 gene) is characterized by male-limited post lingual progressive sensorineural hearing loss of variable severity, with onset in the first to third decades of life. Pedigree and Probability assessment Pedigree Analysis The following pedigree represents the inheritance of a rare disorder in an extended family. What is the most likely mode of inheritance for this disease? (Assume that the trait is fully penetrant.) Pedigree Analysis The pedigree that includes individuals with Charcot-Marie-Tooth disease (CMT). A neurologic disorder that produces dysfunction of the distal extremities with characteristic foot-drop. Which of the following patterns of inheritance is depicted in this pedigree? A. Autosomal Dominant B. Autosomal Recessive C. X-linked Dominant D. X-linked Recessive E. Mitochondrial Risk recurrence If individual III-4 becomes pregnant, what is her risk of having a child with CMT? A. 1/2 B. 1/4 C. 1/8 D. 1/16 E. Virtually 0 The predominance of affected males with transmission through females makes this pedigree diagnostic of X-linked recessive inheritance. Individual I-1 is an obligate carrier, seen by her affected son and grandson. Individual II-2 cannot transmit an X-linked disorder, his daughters are obligate carriers. Individual II-3 is a carrier indicated by her affected son. There is a ¼ probability of recurrence of CMT in her offspring. Risk Recurrence Individual III-4 also has a ½ probability of being a carrier with ¼ (25%) of having an affected offspring like her mother. ½ x ¼ = ⅛ probability of III-4 MCQ A couple from rural Pennsylvania with their four children. Both the parents have normal complexion with brown hair. Of the four children, 2 have brown hair and fair skin, and 2 have white hair and skin and light blue eyes. Physical examination of the 2 lighter children (black circle and square in the pedigree shown) shows strabismus and nystagmus. Which of the following is the probability that IV-3 is a carrier of the trait? A. 1/4 B. 1/3 C. 1/2 D. 2/3 E. 1/1 Pedigree Analysis A a A AA Aa a Aa aa Autosomal recessive inheritance shows a pattern of skipping generations with unaffected parents having affected children as illustrated in the pedigree. the pedigree also reflects consanguineous mating prevalent in autosomal recessive disorders. Albinism is an autosomal recessive disorder generally characterized by a defect in the tyrosinase enzyme. This leads to the inability to produce melanin. ► The Punnett square shows the frequency of genotypes of offspring for two heterozygous parents. ► There is 25% (¼)chance of normal, 50% (½) of carriers and 25% (¼) of affected. ► Since IV-3 and IV-4 are unaffected and not included in the 25% affected. ► Therefore IV-3 and IV-4 are among remaining 75% (¾). There is also a 50% (½) chance of IV-3 being a carrier. Probability of IV-3 being a carrier is: 50% (0.5) ÷ 75% (0.75) =66% (0.66) OR 4 4 ½ ÷ ¾ = ½ x /3 = /6= ⅔ Ans: D Risk recurrence assessment Based on the given pedigree what is the probability that IV-2 will manifest traits for this autosomal recessive disease? Risk recurrence assessment III-2 is a carrier and has a ½ or 50% chance of passing the mutant allele to IV -2 III-3 has a ½ or 50% chance of being a carrier and has a ½ or 50% chance passing the mutant allele to IV-2 ½ x ½ x ½ = ⅛ -----------------------------------------------------------------